PRESS RELEASE published on 08/16/2024 at 08:11, 1 year 7 months ago Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital Annonce du nombre d'actions et de droits de vote de Poxel, une société biopharmaceutique spécialisée dans les traitements contre les maladies métaboliques. Toutes les informations réglementées sont disponibles sur leur site web Droits De Vote Actions Biopharmaceutique Maladies Métaboliques Poxel
BRIEF published on 08/07/2024 at 08:05, 1 year 7 months ago Sumitomo Pharma et Poxel dévoilent les résultats de l'étude sur le TWYMEEG® pour le diabète de type 2 Diabète De Type 2 Insuffisance Rénale TWYMEEG® Poxel Sumitomo Pharma
BRIEF published on 08/07/2024 at 08:05, 1 year 7 months ago Sumitomo Pharma and Poxel Unveil Study Results of TWYMEEG® for Type 2 Diabetes TWYMEEG® Poxel Sumitomo Pharma Type 2 Diabetes Renal Failure
PRESS RELEASE published on 08/07/2024 at 08:00, 1 year 7 months ago Informations privilégiées / Autres communiqués Sumitomo Pharma et Poxel publient les résultats préliminaires de l'étude clinique de TWYMEEG® pour le diabète de type 2 au Japon. Sécurité confirmée, discussions réglementaires prévues Étude Clinique Diabète De Type 2 TWYMEEG® Poxel Sumitomo Pharma
PRESS RELEASE published on 08/07/2024 at 08:00, 1 year 7 months ago Inside Information / Other news releases Sumitomo Pharma and Poxel announce topline results from post-marketing clinical study on TWYMEEG(R) for Type 2 Diabetes treatment in Japan. Safety, tolerability confirmed in renal impairment patients Japan Poxel Sumitomo Pharma Type 2 Diabetes TWYMEEG
Published on 03/26/2026 at 00:30, 20 minutes ago Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results
Published on 03/25/2026 at 19:15, 5 hours 35 minutes ago Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/25/2026 at 13:30, 11 hours 20 minutes ago Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada
Published on 03/25/2026 at 13:30, 11 hours 20 minutes ago Triera Biosciences - a Zentek Company - Launches Contract Research Organization Services for Custom Aptamer Discovery, Biosensor Enablement, and Machine-Learning Classification
Published on 03/25/2026 at 20:00, 4 hours 50 minutes ago Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press
Published on 03/25/2026 at 19:41, 5 hours 9 minutes ago EQS-Adhoc: STRATEC POSTS IMPAIRMENTS, REPORTS PRELIMINARY RESULTS FOR 2025, AND OFFERS GUIDANCE FOR 2026
Published on 03/25/2026 at 19:30, 5 hours 20 minutes ago AIXTRON to expand global footprint with new plant in Malaysia
Published on 03/25/2026 at 19:26, 5 hours 24 minutes ago EQS-Adhoc: AIXTRON SE to expand global footprint with new plant in Malaysia
Published on 03/25/2026 at 18:40, 6 hours 10 minutes ago TULKUBASH AND KYZYLTASH MINING ASSETS: DECLARATION FROM A GROUP OF INVESTORS
Published on 03/25/2026 at 18:53, 5 hours 56 minutes ago CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026
Published on 03/25/2026 at 18:31, 6 hours 19 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 18:31, 6 hours 19 minutes ago Performance soutenue des Investissements et déploiement actif de la stratégie
